Brief: Tevogen Bio’S Effort In Artificial Intelligence, Tevogen Ai, Joins Microsoft For Startups, Begins Accelerating Drug Development

Oct 23 (Reuters) - Microsoft Corp  MSFT.O :
    * TEVOGEN BIO’S EFFORT IN ARTIFICIAL INTELLIGENCE, TEVOGEN
AI,
JOINS MICROSOFT FOR STARTUPS, BEGINS ACCELERATING DRUG
DEVELOPMENT

Source text for Eikon:  ID:nGNX703Dct 
Further company coverage:  MSFT.O 

 ((Reuters.Briefs@thomsonreuters.com))

Recent news on Tevogen

See all news